Your browser doesn't support javascript.
loading
Anhedonia as a potential transdiagnostic phenotype with immune-related changes in recent onset mental health disorders.
Lalousis, Paris Alexandros; Malaviya, Aanya; Khatibi, Ali; Saberi, Majid; Kambeitz-Ilankovic, Lana; Haas, Shalaila S; Wood, Stephen J; Barnes, Nicholas M; Rogers, Jack; Chisholm, Katharine; Bertolino, Alessandro; Borgwardt, Stefan; Brambilla, Paolo; Kambeitz, Joseph; Lencer, Rebekka; Pantelis, Christos; Ruhrmann, Stephan; Salokangas, Raimo K R; Schultze-Lutter, Frauke; Schmidt, Andre; Meisenzahl, Eva; Dwyer, Dominic; Koutsouleris, Nikolaos; Upthegrove, Rachel; Griffiths, Siân Lowri.
Afiliación
  • Lalousis PA; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London; Department of Psychiatry and Psychotherapy, Ludwig Maxmilians University, Munich, Germany; Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Hum
  • Malaviya A; Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom.
  • Khatibi A; Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom.
  • Saberi M; Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom.
  • Kambeitz-Ilankovic L; Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
  • Haas SS; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Wood SJ; Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom; Orygen, the National Centre of Excellence in Youth Mental Health; Melbourne, Australia.
  • Barnes NM; Institute for Clinical Sciences, University of Birmingham, United Kingdom.
  • Rogers J; Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom.
  • Chisholm K; Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom.
  • Bertolino A; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Borgwardt S; Department of Psychiatry, University of Basel, Basel, Switzerland.
  • Brambilla P; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Kambeitz J; Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
  • Lencer R; Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Pantelis C; Melbourne Neuropsychiatry Centre, University of Melbourne, Melbourne, Australia.
  • Ruhrmann S; Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.
  • Salokangas RKR; Department of Psychiatry, University of Turku, Turku, Finland.
  • Schultze-Lutter F; Department of Psychiatry and Psychotherapy, University of Düsseldorf, Düsseldorf, Germany; Department of Psychology, Faculty of Psychology, Airlangga University, Surabaya, Indonesia.
  • Schmidt A; Department of Psychiatry, University of Basel, Basel, Switzerland.
  • Meisenzahl E; Department of Psychiatry and Psychotherapy, University of Düsseldorf, Düsseldorf, Germany.
  • Dwyer D; Orygen, the National Centre of Excellence in Youth Mental Health; Melbourne, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.
  • Koutsouleris N; Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London; Department of Psychiatry and Psychotherapy, Ludwig Maxmilians University, Munich, Germany.
  • Upthegrove R; Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom; Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom; Birmingham Early Interventions Service, Birmingham Women's and Children's NHS Foundation Trust. Electronic address: r.upthegrove@bha
  • Griffiths SL; Institute for Mental Health, University of Birmingham, Birmingham, United Kingdom.
Biol Psychiatry ; 2024 May 30.
Article en En | MEDLINE | ID: mdl-38823495
ABSTRACT

BACKGROUND:

Chronic low-grade inflammation is observed across mental disorders and is associated with difficult-to-treat-symptoms of anhedonia and functional brain changes - reflecting a potential transdiagnostic dimension. Previous investigations have focused on distinct illness categories in those with enduring illness, with few exploring inflammatory changes. We sought to identify an inflammatory signal and associated brain function underlying anhedonia among young people with recent onset psychosis (ROP) and recent onset depression (ROD).

METHOD:

Resting-state functional magnetic resonance imaging, inflammatory markers, and anhedonia symptoms were collected from N=108 (M age=26.2[SD 6.2]years; Female =50) participants with ROP (n=53) and ROD (n=55) from the EU-FP7-funded PRONIA study. Time-series were extracted using the Schaefer atlas, defining 100 cortical regions of interest. Using advanced multimodal machine learning, an inflammatory marker model and functional connectivity model were developed to classify an anhedonic group, compared to a normal hedonic group.

RESULTS:

A repeated nested cross-validation model using inflammatory markers classified normal hedonic and anhedonic ROP/ROD groups with a balanced accuracy (BAC) of 63.9%, and an area under the curve (AUC) of 0.61. The functional connectivity model produced a BAC of 55.2% and an AUC of 0.57. Anhedonic group assignment was driven by higher levels of Interleukin-6, S100B, and Interleukin-1 receptor antagonist, and lower levels of Interferon gamma, in addition to connectivity within the precuneus and posterior cingulate.

CONCLUSION:

We identified a potential transdiagnostic anhedonic subtype that was accounted for by an inflammatory profile and functional connectivity. Results have implications for anhedonia as an emerging transdiagnostic target across emerging mental disorders.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Biol Psychiatry Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Biol Psychiatry Año: 2024 Tipo del documento: Article